Quantum Biopharma
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication (NCT06505239) | Quantum Biopharma | 2024-07-12 |
| Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers (NCT05821387) | Quantum Biopharma | 2023-03-22 |
| Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) (NCT05652907) | Quantum Biopharma | 2023-01-19 |
| Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 (NCT04619706) | Quantum Biopharma | 2020-12-14 |
Track Quantum Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.